Agilent Technologies A
NYSE A
$156.34 +2.65 (+1.72%)
As of: Sep 17, 2026 · 3:59 PM EDT

Agilent Technologies (A) EBT Growth (3y) (2013 - 2026)

Analysis

Agilent Technologies (A) EBT Growth (3y) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 10.40%
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -1.90%
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 49.83%
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 70.10%
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -3.89%
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -7.16%
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 33.16%
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -17.17%
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 32.55%
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -42.21%
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 49.83%
Apr 30, 2026 2.67%
Jan 31, 2026 -3.89%
Oct 31, 2025 -0.96%
Jul 31, 2025 -2.67%
Apr 30, 2025 -7.92%
Jan 31, 2025 4.78%
Oct 31, 2024 -3.63%
Jul 31, 2024 1.61%
Apr 30, 2024 11.06%
Jan 31, 2024 8.91%
Oct 31, 2023 14.07%
Jul 31, 2023 -15.53%
Apr 30, 2023 46.06%
Jan 31, 2023 23.25%
Oct 31, 2022 25.35%
Jul 31, 2022 21.38%
Apr 30, 2022 15.17%
Jan 31, 2022 8.75%
Oct 31, 2021 22.45%